Researchers have developed the downstream section of a new streamlined production method for an emerging virus class.

Bio-Techne Corporation (NASDAQ: TECH) today announced a distribution agreement with the U.S. Pharmacopeia (USP) that ...

Bio-Techne (NASDAQ:TECH) signed a distribution agreement with the U.S. Pharmacopeia (USP) that allows the company to offer USP monoclonal antibody (mAb) and recombinant adeno-associated virus (AAV) ...

Bio-Techne Corporation (NASDAQ: TECH) today announced a distribution agreement with the U.S. Pharmacopeia (USP) that enables the Company to sell USP monoclonal antibody (mAb) and recombinant ...

The global viral clearance market size was US$ 425.9 million in 2021. The global viral clearance market size is estimated to reach US$ 894.9 million by 2030, growing at a compound annual growth rate ...

Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory infections (ALRTIs) in children under five and poses a persistent threat to child health worldwide.

GSK plc has announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted the company's regulatory ...

Japan’s Ministry of Health, Labour and Welfare (MHLW) has accepted UK pharma major GSK’s regulatory application to expand the ...

Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory infections (ALRTIs) in children under five and poses a persistent ...

New Delhi: Amid a fresh wave of COVID-19, Israeli researchers have discovered that a protein from the SARS-CoV-2 virus can cause the immune system to attack healthy cells mistakenly. The study, ...

Finally, recombinant virus have strong replication ability and can activate cellular and humoral immunity (Pascual-Iglesias et al., 2019). Our study developed a TGEV reverse genetic system to rescue ...